Compare Neurocrine Biosciences Inc (NBIX) vs Wolfspeed Inc (WOLF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Wolfspeed Inc — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Wolfspeed Inc trades at $32.4 (market cap $1.53B). The key difference: Neurocrine Biosciences Inc is far larger — about 11.4× Wolfspeed Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Wolfspeed Inc nearer its low. Which is the better fit depends on your goals.
| NBIX | WOLF | |
|---|---|---|
Market Cap | $17.40B | $1.53B |
Sector | Health | Technology |
52-Week High | $180.55 | $73.68 |
52-Week Low | $123.10 | $1.19 |
Enterprise Value | $16.49B | $2.19B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Wolfspeed Inc
Wolfspeed is the global leader in wide bandgap semiconductors, specializing in silicon carbide (SiC) and gallium nitride (GaN) materials and devices. It operates a vertically integrated model, controlling the entire process from raw material substrate production to advanced power modules, serving as a critical infrastructure provider for electric vehicles (EVs), renewable energy, and AI data centers.
Read more on WOLF →
